Bill > A01195

This bill requires health insurance policies to provide coverage for follow-up screening or diagnostic services for lung cancer without imposing patient cost-sharing, subject to specific guidelines. The bill applies to medical and major medical insurance policies, mandating coverage for lung cancer follow-up services recommended by healthcare providers and aligned with nationally recognized clinical practice guidelines. These guidelines are defined as evidence-based, peer-reviewed clinical recommendations developed by independent organizations or medical professional societies, using a transparent methodology and conflict of interest policy. The bill allows for medical management and utilization review to ensure services are consistent with established guidelines. For high-deductible health plans, coverage may be subject to the annual deductible if applying the requirement would impact health savings account eligibility. The legislation will take effect on January 1, 2027, and will apply to all insurance policies issued, renewed, modified, altered, or amended on or after that date, with the goal of improving access to lung cancer screening and diagnostic services while reducing financial barriers for patients.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A1195